|
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
|
5R25CA221738-02
|
$409,851
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Washington Womens Interagency HIV/AIDS Study
|
3U01AI034994-24S1
|
$106,140
|
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
|
1T32CA217834-01A1
|
$241,750
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
2P30CA177558-06
|
$2,152,710
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-18
|
$1,913,800
|
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors
|
5F99CA222742-02
|
$31,397
|
|
WILLIAMS, ANNALYNN
|
UNIVERSITY OF ROCHESTER
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
5U01CA164973-07
|
$3,418,975
|
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding causal effects of a treatment on survival in observational studies with unmeasured confounding and an application to effect of PMRT on breast cancer patients
|
5R03CA208387-02
|
$88,836
|
|
YANG, FAN
|
UNIVERSITY OF COLORADO DENVER
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
5U54CA221208-02
|
$670,069
|
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers
|
5U01DK108320-04
|
$190,000
|
|
FORSMARK, CHRISTOPHER
|
UNIVERSITY OF FLORIDA
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy
|
5F99CA222711-02
|
$44,524
|
|
SCHARPING, NICOLE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Training program to promote diversity in cancer research
|
1R25CA229105-01
|
$125,517
|
|
WATABE, KOUNOSUKE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Training Program in Cancer Biology and Therapeutics
|
2T32CA071345-21A1
|
$394,619
|
|
HABER, DANIEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Training Program For Cancer Prevention and Control
|
1T32CA229114-01
|
$150,020
|
|
SHIELDS, PETER
|
OHIO STATE UNIVERSITY
|
|
Training in Translational Research of Lung, Head and Neck Cancer
|
2T32CA174648-06
|
$427,216
|
|
WANG, XIAO-JING
|
UNIVERSITY OF COLORADO DENVER
|
|
Tobacco Treatment in the Context of Lung Cancer Screening
|
5K07CA214839-02
|
$179,784
|
|
ROJEWSKI, ALANA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
5U54CA221204-02
|
$673,579
|
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS
|
5R01CA203995-02
|
$348,844
|
|
MAHER, CHRISTOPHER
|
WASHINGTON UNIVERSITY
|
|
The role of DNMT3A in gene regulation and stem cell expansion
|
5F99CA222736-02
|
$44,524
|
|
HUANG, YUNG-HSIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The regulation of mutant p53 protein accumulation and GOF activity in tumors
|
5F99CA222734-02
|
$29,323
|
|
ZHAO, YUHAN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
The Pacific Northwest Prostate Cancer SPORE
|
2P50CA097186-16A1
|
$2,155,387
|
|
NELSON, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Ohio State University Pancreatic Disorders Network (OSU-PDN)
|
5U01DK108327-04
|
$190,000
|
|
CONWELL, DARWIN
|
OHIO STATE UNIVERSITY
|
|
The MC1R protein palmitoylation in melanoma development
|
1R01CA224432-01A1
|
$386,267
|
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The impact of health literacy, culture and psychosocial factors on the Pap testing behaviors of African immigrant women in the United States
|
5F31CA221096-02
|
$44,524
|
|
CUDJOE, JOYCELYN
|
JOHNS HOPKINS UNIVERSITY
|
|
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
|
5U01DK108288-04
|
$190,000
|
|
CHARI, SURESH
|
MAYO CLINIC ROCHESTER
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
The biochemical, topological and functional impact of cancer associated Ctcf mutations and their contribution to cancer
|
1R01CA229235-01
|
$481,945
|
|
SKOK, JANE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine
|
5U24CA215109-02
|
$1,667,436
|
|
PRIOR, FRED
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$18,955
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targeting Neuroblastoma with armed T cells
|
5R01CA182526-05
|
$1
|
|
LUM, LAWRENCE
|
UNIVERSITY OF VIRGINIA
|
|
Targeting inflammation and immune response in HNSCC therapy
|
5F99CA223062-02
|
$30,062
|
|
ESPINOSA-COTTON, MADELYN
|
UNIVERSITY OF IOWA
|
|
Targeting hyaluronan synthesis and signaling with BET inhibitors in pancreatic cancer
|
5R21CA220625-02
|
$171,825
|
|
KUMAR, KRISHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting Hepatocyte Growth Factor Processing and Activation in Lung Cancer
|
1R43CA224832-01A1
|
$299,980
|
|
KLAMPFER, LIDIJA
|
PROTEXASE THERAPEUTICS, INC.
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies
|
5R44CA162629-03
|
$833,374
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Surgical Oncology Research Training Program
|
1T32CA229102-01
|
$145,292
|
|
KENNEDY, GREGORY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication
|
5R01CA211350-02
|
$348,844
|
|
CAI, CHANGMENG
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
Student-Centered Pipeline to Advance Research in Cancer Careers (SPARCC) for Underrepresented Minority Students
|
1R25CA221715-01A1
|
$183,289
|
|
RADER, JANET
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases
|
5R50CA221830-02
|
$188,413
|
|
PARK, EUNYOUNG
|
DANA-FARBER CANCER INST
|
|
Stress Inflammation Mechanisms of Survivorship Disparities Experienced by Hispanic Women After Breast Cancer
|
5R21CA215007-02
|
$166,931
|
|
PACE, THADDEUS
|
UNIVERSITY OF ARIZONA
|
|
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
|
5U01CA218422-02
|
$535,530
|
|
GAO, JINMING
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
|
5R35CA220434-02
|
$1,010,214
|
|
WEISSMAN, IRVING
|
STANFORD UNIVERSITY
|
|
SPORE in Ovarian Cancer
|
1P50CA228991-01
|
$2,492,537
|
|
SHIH, IE-MING
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Gastrointestinal Cancers
|
2P50CA062924-24A1
|
$2,500,000
|
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
Total relevant funding to Alcoholism Research for this search: $320,105
|